About Celltrion
Celltrion is a company based in Incheon (South Korea) founded in 2002.. The company has 2,900 employees as of December 31, 2024. Celltrion has completed 1 acquisition, including iQone Healthcare Group. Celltrion offers products and services including Biosimilars and R&D Services.
- Headquarter Incheon, South Korea
- Employees 2900 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Celltrion, Inc.
-
Annual Revenue
$2.41 B (USD)63.45as on Dec 31, 2024
-
Net Profit
$286.61 M (USD)-21.09as on Dec 31, 2024
-
EBITDA
$617.22 M (USD)1.47as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
2900
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Celltrion
Celltrion is a publicly listed company on the KRX with ticker symbol 068270 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Celltrion
Celltrion offers a comprehensive portfolio of products and services, including Biosimilars and R&D Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Biosimilars are developed and manufactured for various therapeutic areas such as immunology and oncology.
R&D services are provided for biopharmaceutical development, including clinical trials and regulatory affairs.
Funding Insights of Celltrion
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2010 | Amount | Post-IPO - Celltrion | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Celltrion
Celltrion has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Temasek. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Celltrion
Celltrion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include iQone Healthcare Group. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of biosimilar and breakthrough medicines distribution
|
1979 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Celltrion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Celltrion Comparisons
Competitors of Celltrion
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Celltrion
Frequently Asked Questions about Celltrion
When was Celltrion founded?
Celltrion was founded in 2002 and raised its 1st funding round 8 years after it was founded.
Where is Celltrion located?
Celltrion is headquartered in Incheon, South Korea.
Who is the current CEO of Celltrion?
Woo-Sung Kee is the current CEO of Celltrion.
How many employees does Celltrion have?
As of Dec 31, 2024, the latest employee count at Celltrion is 2,900.
What is the annual revenue of Celltrion?
Annual revenue of Celltrion is $2.41B as on Dec 31, 2024.
What does Celltrion do?
Founded in 2002 in Incheon, South Korea, the company operates in the biotechnology sector, focusing on antibody biosimilars. Rensima, a biosimilar to infliximab, is utilized for treating rheumatoid arthritis and other autoimmune conditions. Additional biosimilars in development include versions of rituximab, adalimumab, bevacizumab, palivizumab, cetuximab, and etanercept. In 2020, annual revenues of 1.6 billion and net profit of 433.3 million were recorded.
What products or services does Celltrion offer?
Celltrion offers Biosimilars and R&D Services.
Is Celltrion publicly traded?
Yes, Celltrion is publicly traded on KRX under the ticker symbol 068270.
How many acquisitions has Celltrion made?
Celltrion has made 1 acquisition, including iQone Healthcare Group.
Who are Celltrion's investors?
Celltrion has 1 investor. Key investors include Temasek.
What is Celltrion's ticker symbol?
The ticker symbol of Celltrion is 068270 on KRX.